$Teradyne (TER.US)$Selected in the analysis in March 2022 du...

Listed in 1970, mainly engaged in the business of automatic testing systems, operating in global markets, with the current price at 101.81.

In the past 5 years, revenue, operating profit, and net income have all increased for the first 3 years, but have declined in the last two years, with profits now lower than they were 5 years ago.

Currently, the P/E ratio is 37.3, the 5-year average net income of 0.69 billion corresponds to a P/E ratio of 22.6, indicating an unattractive valuation.